estimation of tissue reduced glutathione Mechanism the conjugation to the CDNB. Step 1: Rapid determination of reduced and
Description
A from 0.0 ppm to 4.8 ppm the peptide bond conformation is predicted to be 100% trans , whereas from 9.15 ppm to 14.4 ppm to be 100% cis

To enable safe clinical exploration, pharmacodynamic monitoring should be embedded from the outset, using biomarkers of lipid peroxidation and cellular redox status to verify on-lesion activity, coupled with early indicators of marrow and mitochondrial injury to guide dose adjustment (101)

Nature 550 , 6166 (2017)

Combining biomarker data (B12 levels, MMA, homocysteine), genetic insights from your Precision Peptide test, and clinical assessment with your provider creates a more informed foundation for deciding whether B12/Mic injections are right for you and how to monitor their effectiveness over time
